RxDoctor Payments Data

Robert Winn, MD

Family Medicine · Haddon Township, NJNPI 1629096821

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Viiv Healthcare Company at 29.3% of the total. Reporting peaked in 2022 at $765 and has fallen 62.0% since, to $290 in 2025.

$2,729in general payments, 2019–2025

Across 205 payments — averaging $13.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$798
  • Gilead$597
  • AbbVie$278
  • Otsuka America Pharmaceutical, Inc.$133
  • Braeburn Inc.$131
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$112
  • plus $679 from 16 others
$42in research payments, 2019–2025

Across 2 payments — averaging $20.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$42

What the payments were for

  • Food & beverage$2,70099%
  • Education$281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,729 in reported general payments places this provider in the 80th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024
$36,022
Medicare patients
77
Services billed
400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl205$24,425
BrilintaTicagrelor16$9,608
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine127$2,188
Alprazolam115$1,410
Testosterone Cypionate19$769
Gabapentin46$697
Morphine Sulfate ErMorphine Sulfate23$643
Oxycodone Hcl39$620
Clonazepam62$574
Albuterol Sulfate HfaAlbuterol Sulfate28$559
Buprenorphine Hcl20$532
Cyclobenzaprine Hcl25$458
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$436
Duloxetine Hcl22$378
Montelukast Sodium49$339

Paid to pharmacies, not to this prescriber.

Other family medicine in Haddon Township

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →